| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18646 R79249 |
Christensen (Controls exposed to LTG/LEV), 2024 | Major congenital malformations | Paternal exposure: genotoxic/epigenetic window (0–xxx months preconception) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: Yes Paternal ASMs: mono/polytherapy or not specified |
0.67 [0.46;0.98] excluded (control group) |
48/1,336 84/1,663 | 132 | 1,336 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18644 R79230 |
Christensen (Controls unexposed, general pop), 2024 | Major congenital malformations | Paternal exposure: genotoxic/epigenetic window (0–xxx months preconception) | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: Yes Paternal ASMs: monotherapy |
0.83 [0.59;1.17] excluded (control group) |
-/1,017 43,855/1,234,017 | - | 1,017 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18647 R79252 |
Christensen (Controls unexposed, sibling), 2024 | Major congenital malformations | Paternal exposure: genotoxic/epigenetic window (0–xxx months preconception) | population based cohort retrospective | sibling excluded | Adjustment: Yes Paternal ASMs: mono/polytherapy or not specified |
0.72 [0.30;1.70] excluded (control group) |
10/303 16/381 | 26 | 303 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18645 R79239 |
Christensen (Controls unexposed, sick), 2024 | Major congenital malformations | Paternal exposure: genotoxic/epigenetic window (0–xxx months preconception) | population based cohort retrospective | unexposed, sick | Adjustment: Yes Paternal ASMs: mono/polytherapy or not specified | 0.81 [0.58;1.14] | 35/1,052 481/11,308 | 516 | 1,052 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18640 R79224 |
Tomson, 2020 | Major malformations | Paternal exposure: genotoxic/epigenetic window (0–xxx months preconception) | population based cohort retrospective | unexposed, sick | Adjustment: Yes Paternal ASMs: monotherapy | 0.90 [0.60;1.50] | 22/458 121/2,457 | 143 | 458 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 2 studies | 0.84 [0.64;1.10] | 659 | 1,510 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 18646, 18644, 18647